NCT04871204View on ClinicalTrials.gov

Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 16, 2021

Primary Completion Date

February 21, 2024

Study Completion Date

February 21, 2024

Conditions
Esophageal CancerGastric Cancer
Interventions
DRUG

Octreotide Injection

10 mg Sandostatin LAR intramuscular injection

Trial Locations (1)

Unknown

Karolinska University Hospital, Huddinge, Stockholm

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

lead

Fredrik Klevebro

OTHER